CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net income	$ 14,277	$ 13,079
Provision (credit) for loan and lease losses	(211)	(80)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,599	1,537
Write down of other real estate, net of gain on sale	256	(162)
Amortization of core deposit premium and mortgage servicing rights	1,126	1,188
Net amortization and accretion of premium/discounts on investment securities	2,922	2,966
Share-based compensation	399	498
Net gain on sales of residential mortgage loans	(972)	(1,312)
Proceeds from sales of loans held for sale	64,106	86,663
Originations of loans held for sale	(54,290)	(63,375)
Equity in earnings of unconsolidated subsidiaries	(43)	(61)
Net increase in cash surrender value of bank-owned life insurance	(318)	(208)
Deferred income taxes	3,620	6,685
Net tax benefits from share-based compensation	72	125
Net change in other assets and liabilities	(3,198)	(2,373)
Net cash provided by operating activities	29,345	45,170
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available-for-sale	40,039	49,204
Purchases of investment securities available-for-sale	(85,240)	(107,512)
Proceeds from maturities of and calls on investment securities held-to-maturity	14,545	6,069
Net loan proceeds (originations)	(46,144)	2,111
Purchases of loan portfolios	0	(24,121)
Proceeds from sale of foreclosed loans/other real estate owned	40	102
Proceeds from bank-owned life insurance	0	782
Purchases of premises and equipment	(687)	(1,582)
Net return of capital from unconsolidated subsidiaries	539	438
Net (purchases of) proceeds from redemption of FHLB stock	(1,246)	4,239
Net cash used in investing activities	(78,154)	(70,270)
Cash flows from financing activities:
Net increase in deposits	24,077	169,243
Net (decrease) increase in short-term borrowings	24,000	(114,000)
Cash dividends paid on common stock	(5,670)	(4,922)
Repurchases of common stock and other related costs	(10,111)	(3,529)
Net cash provided by financing activities	32,296	46,792
Net increase (decrease) in cash and cash equivalents	(16,513)	21,692
Cash and cash equivalents at beginning of period	82,293	84,341
Cash and cash equivalents at end of period	65,780	106,033
Cash received during the period for:
Income taxes	4,877	2,396
Supplemental disclosure of non-cash investing and financing activities:	22	0
Net reclassification of loans to foreclosed loans/other real estate owned	$ 40	$ 0

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.